![]() |
||
| Home | Firm Description | Sectors Covered | Completed Transactions | Testimonials | Principals | M&A Report and Publications |
Contact Us |
| Acquiring Party | Angiotech Pharmaceuticals, Inc., a specialty pharmaceutical company that develops treatments for complications associated with medical device implants, surgical interventions and acute injury or trauma. |
|---|---|
| Transferring Party | American Medical Instruments Holdings, Inc., a leading independent manufacturer of a single-use medical device products for vascular surgery, interventional radiology, general surgery, wound closure, and minimally-invasive cosmetic surgery. |
| Sector | Medical Devices |
| Date | March 23, 2006 |
| Analysis Diversifies Angiotech's revenue base and provides manufacturing, marketing and sales capabilities in a several therapeutic areas. AMI was formed in 2003 following the purchase of a majority interest in several medical technology companies by RoundTable Healthcare Partners from The Marmon Group. Deal value $785m, on sales $174m(4.5x). | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |